MRD / Regn No. : SG000879 Date : 22/07/2026
Patient Name : MANIKA SAMANTA Age & Gender : 45 Yrs. / Female
Contact No. : 9062446859 UHID :
Ht / Wt / BMI : 162 / 127 / 48.39 BP S / BP D : 105 / 106
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (24/Feb/2023) | HYPERTENSION (24/Feb/2023) | DYSLIPIDEMIA (24/Feb/2023) | OBESITY (21/Feb/2025) | MICROALBUMINURIA (21/Feb/2025) |
Salient Investigations : CREATININE: 0.64 | EGFR EGLOMERULAR FILTRATION RATE: 107.49 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 117 mg/dL | HB HEMOGLOBIN: 13.3 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 5.6 % | POST PRANDIAL GLUCOSE (2HPP): 128 mg/dL | URIC ACID: 2.8
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET ROSUVASTATIN 10 MG
STATEZE R 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
2 TABLET TELMISARTAN 40 MG + CILNIDIPINE 10 MG
APEL CL 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
3 TABLET DAPAGLIFLOZIN 10 MG
UDAPA
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
4 ANTIHYPERGLYCEMIC SEMAGLUTIDE 2.4 MG
NOVELTREAT 2.4 MG 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 22/Oct/2026
Tests Suggested For Next Visit : HBA1C-HPLC METHOD,CREATININE,ECG (ALL LEADS)
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: